It influences the migration and infiltration of immune cells into tumor tissues by modulating chemokines (e.g., CXCL12) and adhesion molecules (e.g., ICAM-1) (144), and affects immune cell activation and anti-tumor responses by regulating the expression and function of immune cell surface receptors (145). The gene discussed is CXCL12; the disease is neoplasm.